Alzheimer Disease, Early Onset Clinical Trial
— MIMA-POfficial title:
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
Patients with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD) may or may not develop Alzheimer's disease (AD) dementia. Yet identifying patients at risk is crucial: delaying the onset of the disease by 5 years could reduce prevalence by 50%. To achieve this, we need affordable biomarkers combined with clinically meaningful assessment tools. Current approaches (cognition, imaging or Tau and Amyloid peptide assays) lack precision or specificity (e.g., age-related memory deficits) and involve invasive and costly procedures, sometimes inaccessible in France (e.g., the "AT(N)" framework). Recently, quantitative diffusion MRI (dMRI) has identified in-vivo gray matter microstructural changes linked to hyperphosphorylated Tau protein, which are of great diagnostic value. Still, we ignore whether and how these changes are responsible for early memory impairment in AD. The MIMA-P project will combine multi-compartment models of the high-resolution diffusion signal with a cognitive assessment of memory based on recent models of medial temporal lobe function to assess the relevance of a new affordable, rapid and non-invasive early marker of the disease.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | July 2026 |
Est. primary completion date | November 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 80 Years |
Eligibility | Inclusion Criteria: - aged between 50 and 80 - native French speaking - right-handed - with a level of education equal to or higher than the Certificat d'Etudes Primaires (primary school leaving certificate) - free of any medical or psychiatric condition likely to interfere with cognition, other than a diagnosis of SCD / MCI - affiliated with a social security scheme - having received oral and written information abou the protocol and having signed a consent form to participate in this research - patients with 'subjective cognitive decline-plus' (hereafter 'SCD', criteria of Jessen et al., 2014) or patients with mild neurocognitive impairment due to Alzheimer's disease (hereafter 'MCI', criteria of Albert et al., 2011) Exclusion Criteria: - contraindications to MRI : Abdominal circumference + upper limbs stuck to the body > 200 cm; Implantable pacemaker or defibrillator; Neurosurgical clips; Cochlear implants ; Neural or peripheral stimulator; Intra-orbital or encephalic metallic foreign bodies; Endoprostheses fitted less than 4 weeks ago and osteosynthesis devices fitted less than 6 weeks ago; Claustrophobia. - sensory deficit interfering with experimental tests - pregnant or breast-feeding women - adults under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty - 7-items modified Hachinski ischemic score >2 (Hachinski et al., 2012) - Dementia (McKhann et al., 2011) |
Country | Name | City | State |
---|---|---|---|
France | CHU Rennes | Rennes |
Lead Sponsor | Collaborator |
---|---|
Rennes University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure | Free-water and free-water corrected Fractional anisotropy are two parameters that can be estimated through Multi-Compartment Modelling of the diffusion MRI signal within medial temporal lobes gray matter. We will compute these parameters for the hippocampus and the surroundings rhinal cortices. These measures will be compared between patients and healthy controls. | 2 hours and 30 minutes | |
Secondary | Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure | Free-water and free-water corrected Fractional anisotropy are two parameters that can be estimated through Multi-Compartment Modelling of the diffusion MRI signal within medial temporal lobes gray matter. We will compute these parameters for the hippocampus and the surroundings rhinal cortices. These measures will be compared across patients groups. | 2 hours and 30 minutes | |
Secondary | Relationships between medial temporal lobe gray matter microstructure and memory | Free-water and free-water corrected Fractional anisotropy are two parameters that can be estimated through Multi-Compartment Modelling of the diffusion MRI signal within medial temporal lobes gray matter. We will compute these parameters for the hippocampus and the surroundings rhinal cortices. Memory accuracy scores will be computed for the two memory tasks "The '4 mountains test' and the 'Memory entities' test" . Correlational analyses will be performed across groups between gray matter microstructure estimates and memory scores. | 2 hours and 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03625401 -
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT05983575 -
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT05989087 -
The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
|
||
Recruiting |
NCT06080659 -
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
|
N/A | |
Not yet recruiting |
NCT05604183 -
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT03514875 -
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
|
N/A | |
Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
Completed |
NCT03706885 -
Efavirenz for Patients With Alzheimer's Disease
|
Phase 1 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Not yet recruiting |
NCT05006599 -
SNIFF - 3-Week Aptar CPS Device
|
Phase 2 | |
Recruiting |
NCT02740634 -
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
|
N/A | |
Active, not recruiting |
NCT03069391 -
The Interactive Physical and Cognitive Exercise System
|
N/A | |
Recruiting |
NCT04701957 -
The Ketogenic Diet for Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06268886 -
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
|
Phase 2 | |
Recruiting |
NCT04100889 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
|
||
Recruiting |
NCT04656860 -
Juice Plus Supplement Clinical Trial
|
N/A | |
Recruiting |
NCT05315895 -
The Dampness Syndrome of Chinese Medicine Cohort Study
|
||
Recruiting |
NCT04916964 -
Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial)
|
N/A | |
Recruiting |
NCT04804618 -
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Recruiting |
NCT04680013 -
Genetic Studies in Familial Dementia
|